A review in Current Allergy and Asthma Reports highlights how acute exacerbations of chronic rhinosinusitis (AECRS) remain poorly defined, inconsistently diagnosed, and often overtreated with ...

Please provide your email address to receive an email when new articles are posted on . 15.4% of the population had frequent exacerbations. Greater frequency was associated with higher corticosteroid ...

Treatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic ...

Patients with acute COPD exacerbations are seen frequently in the emergency department (ED). Acute exacerbations are associated with significant morbidity, mortality and health care expenditures.

Table 1 reports the total number of patients with COPD and the number experiencing an MI or stroke. There were 25,857 patients with COPD in 277 practices at the start of the observation period. Over ...

Please provide your email address to receive an email when new articles are posted on . Moderate exacerbations shared similar characteristics with severe exacerbations. Lung function, limitations and ...

In double-blind, placebo-controlled trials, budesonide–formoterol used on an as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed use of a short-acting β 2-agonist ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil counts ...

The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.